OrbiMed’s CeriBell Inc CBLL Stock Holding History

OrbiMed’s Portfolio CBLL Stock Details CBLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-112,500	Closed	-$2.16M	–	127
2025 Q1	$2.16M	Hold	112,500	–	–	0.05%	91
2024 Q4	$2.91M	Buy	+112,500	New	+$3.07M	0.06%	97

Other funds holding CBLL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

RTM

Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Yu Fan $108M AUM 137.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

OrbiMed's CBLL Position: Q2 2025 in Review

OrbiMed sold out of CeriBell Inc (CBLL) in Q2 2025, closing a stake of 112,500 shares — an estimated $2.16M sold.

OrbiMed first reported a position in CBLL in Q4 2024 and held it in 2 quarters. The position peaked at $2.91M in Q4 2024. 95 funds tracked by Wall St. Rank hold CBLL as of Q2 2025.

OrbiMed reported no remaining CeriBell Inc position as of Q2 2025 after selling out during the quarter.
OrbiMed sold 112,500 CeriBell Inc shares in Q2 2025, an estimated $2.16M.
OrbiMed first reported a position in CeriBell Inc in Q4 2024 and held it in 2 quarters.
OrbiMed's CeriBell Inc position peaked at $2.91M in Q4 2024.
95 funds tracked by Wall St. Rank held CeriBell Inc as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.